Inhibition of cellular transformation by berry extracts

Area of Science:

• Chemoprevention
• Natural Products Chemistry
• Cell Biology

Background:

• Berries like strawberries and black raspberries are investigated for cancer chemopreventive properties.
• Ellagic acid, a key berry component, inhibits carcinogenesis, but other compounds may also contribute.
• The Syrian hamster embryo (SHE) cell transformation model is used to assess anti-cancer effects.

Purpose of the Study:

• To evaluate the anti-transformation activity of strawberry (FA) and black raspberry (RU) extracts.
• To compare the effects of specific fractions (FA-ME, RU-ME) and ellagic acid against benzo[a]pyrene (B[a]P)-induced transformation.
• To elucidate the potential mechanisms of chemopreventive action.

Main Methods:

• Freeze-dried strawberries (FA) and black raspberries (RU) were fractionated.
• Fractions and ellagic acid were tested for anti-transformation activity in SHE cells treated with B[a]P.
• Time-course experiments (co-treatment and post-treatment) were conducted to assess inhibitory effects.

Main Results:

• Ellagic acid, FA-ME, and RU-ME fractions demonstrated dose-dependent inhibition of B[a]P-induced cell transformation.
• FA-ME and RU-ME showed significant inhibition only during a 24-hour co-treatment with B[a]P.
• Ellagic acid inhibited transformation in both co-treatment and post-treatment protocols.

Conclusions:

• Methanol extracts (FA-ME, RU-ME) from strawberries and black raspberries exhibit cancer chemopreventive activity.
• These extracts may act by interfering with the uptake, activation, or detoxification of B[a]P, or by affecting DNA binding/repair.
• The findings support the potential of berry-derived compounds, beyond ellagic acid, in cancer chemoprevention strategies.